Asthma drug may shield hearts from chemo damage
NCT ID NCT05959889
Summary
This study tested whether montelukast, a common asthma medication, could help protect the heart from damage caused by the chemotherapy drug doxorubicin in breast cancer patients. Fifty patients were split into two groups: one received montelukast and the other received a placebo while undergoing chemotherapy. Researchers measured specific blood markers related to heart stress and inflammation to see if the drug made a difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Damanhour Oncology Center
Damanhūr, Elbehairah, 31527, Egypt
Conditions
Explore the condition pages connected to this study.